Latest Medical Press Releases

Profound Autism Alliance Funds ECHO Autism Program to Improve Care for Those with Intense Behaviors

October 30, 2023

Profound Autism Alliance Funds ECHO Autism Program to Improve Care for Those with Intense Behaviors

DOVER, USA. October 30th, 2023 - The Profound Autism Alliance (PAA) is proud to announce the launch of its first project, ECHO Autism: Intense Behavior.  Funded by the Profound Autism Alliance, ...
Read More
Leverage your last mile – Is Mark Cuban a partner for the independent pharmacy?

October 27, 2023

Leverage your last mile – Is Mark Cuban a partner for the independent pharmacy?

Why would a patient pay $8 for same-day delivery through a digital pharmacy startup? There is no other business model that provides free same-day home delivery other than independent pharmacies. Yo...
Read More
Leverage your last mile – Is Mark Cuban a partner for the independent pharmacy?

October 27, 2023

Leverage your last mile – Is Mark Cuban a partner for the independent pharmacy?

Why would a patient pay $8 for same-day delivery through a digital pharmacy startup? There is no other business model that provides free same-day home delivery other than independent pharmacies. Yo...
Read More
Rainbird Announces Partnership with Relanto to Combine Explainable AI and Human-Centric Business Transformation

October 27, 2023

Rainbird Announces Partnership with Relanto to Combine Explainable AI and Human-Centric Business Transformation

NORWICH, UK 18th April 2023 - Rainbird Technologies has formed a strategic partnership with Relanto, a global consulting and professional services firm specializing in AI-driven enterprise planning...
Read More
Excivion announces results of an international collaboration evaluating the utility of its novel point-of-care dengue and Zika antibody tests

October 27, 2023

Excivion announces results of an international collaboration evaluating the utility of its novel point-of-care dengue and Zika antibody tests

CAMBRIDGE UK – Excivion Ltd (www.excivion.com), a biotechnology company developing novel vaccines based on its proprietary glycan-cloaking molecular design and adjuvant platforms, today announce...
Read More
PharmiWeb Launches New US-Focused Life Science Job Board

October 27, 2023

PharmiWeb Launches New US-Focused Life Science Job Board

Berkshire, UK. 11th October 2021. PharmiWeb.jobs, Europe's largest dedicated Life Science Job Board, has today launched a new US-focused version of their site. www.PharmiWeb.jobs/US/ The new site ...
Read More
Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality

October 27, 2023

Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality

Revax Biotech announce their response to the G7/WHO Challenge enabling vaccines to be available to meet existing or emerging respiratory pandemic threats in 100 days or less. Revax Biotech is a UK...
Read More
PharmiWeb Launches New US-Focused Life Science Job Board

October 27, 2023

PharmiWeb Launches New US-Focused Life Science Job Board

Berkshire, UK. 11th October 2021. PharmiWeb.jobs, Europe's largest dedicated Life Science Job Board, has today launched a new US-focused version of their site. www.PharmiWeb.jobs/US/ The new site ...
Read More
Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System

October 27, 2023

Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System

Lausanne, Switzerland, 14 September 2022  - Aleva Neurotherapeutics SA, the company that pioneered Directional Deep Brain Stimulation (DBS) in Neuromodulation, announces the CE approval of its MRI...
Read More
Massive Bio Publishes the Second Issue of Massive Bio magazine

October 27, 2023

Massive Bio Publishes the Second Issue of Massive Bio magazine

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...
Read More
Esya Labs Awarded $452,000 Grant from the Michael J. Fox Foundation (MJFF) to Develop Peripheral Biomarkers for Parkinson’s Disease

October 27, 2023

Esya Labs Awarded $452,000 Grant from the Michael J. Fox Foundation (MJFF) to Develop Peripheral Biomarkers for Parkinson’s Disease

London, UK, November 4th, 2022 – Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been awarded a grant of $452,000 from The Michael J. Fox F...
Read More
Massive Bio Publishes the Second Issue of Massive Bio magazine

October 27, 2023

Massive Bio Publishes the Second Issue of Massive Bio magazine

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...
Read More